Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age

Abbey Berenson, Tabassum H. Laz, Jacqueline Hirth, Christine J. McGrath, Mahbubur Rahman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The purpose of this study was to examine the relationship between human papillomavirus (HPV) vaccine uptake among adolescents aged 9-17 years and the decision-making process used by families in determining whether to vaccinate their children against HPV. A cross-sectional sample of women with at least one child aged 9-17 years (n = 1256) was recruited from 3 reproductive health clinics in Southeast Texas during 2011-2013. Self-administered survey included questions about the HPV vaccination decision-making process, HPV vaccine uptake (initiation and 3-dose series completion), and demographics. Among mothers with at least one 9 to 17-year-old daughter (n = 783), 40% independently decided whether or not to vaccinate their daughter against HPV, 22% involved their husbands/partners, and 31% their daughters. Only 7% of respondents reported other formats in the decision-making (husband/partner alone or daughter alone). Similarly, for women with at least one eligible son (n = 759), 39% decided alone, 30% with their husbands/partners, 24% with their sons, and 7% reported other formats. Among mothers with a daughter, those who made the decision independently were more likely to report that their daughters had initiated the HPV vaccine series (30%) compared with women who included their husbands/partners (10%) or daughters (20%) in the decision process or stated other types (18%) of decision making (P < 0.001). The respective figures for the completion of the entire series among daughters were 16%, 6%, 11%, and 11% (P = 0.012). Among mothers with a son, a similar scenario was observed for vaccine initiation (17%, 4%, 10%, and 0%, respectively) (P < 0.001) and completion (7%, 1%, 4%, and 0%, respectively) (P = 0.003). These associations remained significant after adjusting for confounder variables. Awareness programs to increase HPV vaccine uptake should include both parents and children, as all have an important role in deciding whether or not children will be vaccinated.

Original languageEnglish (US)
Pages (from-to)1807-1811
Number of pages5
JournalHuman Vaccines and Immunotherapeutics
Volume10
Issue number7
DOIs
StatePublished - Jul 1 2014

Fingerprint

Nuclear Family
Decision Making
Vaccination
Papillomavirus Vaccines
Spouses
Mothers
Reproductive Health
Vaccines
Parents
Demography

Keywords

  • Adolescents
  • Decision-making
  • HPV vaccine
  • Human papillomavirus
  • Parents

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age. / Berenson, Abbey; Laz, Tabassum H.; Hirth, Jacqueline; McGrath, Christine J.; Rahman, Mahbubur.

In: Human Vaccines and Immunotherapeutics, Vol. 10, No. 7, 01.07.2014, p. 1807-1811.

Research output: Contribution to journalArticle

@article{5343e325036b49428c3a3df36ca17a69,
title = "Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age",
abstract = "The purpose of this study was to examine the relationship between human papillomavirus (HPV) vaccine uptake among adolescents aged 9-17 years and the decision-making process used by families in determining whether to vaccinate their children against HPV. A cross-sectional sample of women with at least one child aged 9-17 years (n = 1256) was recruited from 3 reproductive health clinics in Southeast Texas during 2011-2013. Self-administered survey included questions about the HPV vaccination decision-making process, HPV vaccine uptake (initiation and 3-dose series completion), and demographics. Among mothers with at least one 9 to 17-year-old daughter (n = 783), 40{\%} independently decided whether or not to vaccinate their daughter against HPV, 22{\%} involved their husbands/partners, and 31{\%} their daughters. Only 7{\%} of respondents reported other formats in the decision-making (husband/partner alone or daughter alone). Similarly, for women with at least one eligible son (n = 759), 39{\%} decided alone, 30{\%} with their husbands/partners, 24{\%} with their sons, and 7{\%} reported other formats. Among mothers with a daughter, those who made the decision independently were more likely to report that their daughters had initiated the HPV vaccine series (30{\%}) compared with women who included their husbands/partners (10{\%}) or daughters (20{\%}) in the decision process or stated other types (18{\%}) of decision making (P < 0.001). The respective figures for the completion of the entire series among daughters were 16{\%}, 6{\%}, 11{\%}, and 11{\%} (P = 0.012). Among mothers with a son, a similar scenario was observed for vaccine initiation (17{\%}, 4{\%}, 10{\%}, and 0{\%}, respectively) (P < 0.001) and completion (7{\%}, 1{\%}, 4{\%}, and 0{\%}, respectively) (P = 0.003). These associations remained significant after adjusting for confounder variables. Awareness programs to increase HPV vaccine uptake should include both parents and children, as all have an important role in deciding whether or not children will be vaccinated.",
keywords = "Adolescents, Decision-making, HPV vaccine, Human papillomavirus, Parents",
author = "Abbey Berenson and Laz, {Tabassum H.} and Jacqueline Hirth and McGrath, {Christine J.} and Mahbubur Rahman",
year = "2014",
month = "7",
day = "1",
doi = "10.4161/hv.28779",
language = "English (US)",
volume = "10",
pages = "1807--1811",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "7",

}

TY - JOUR

T1 - Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age

AU - Berenson, Abbey

AU - Laz, Tabassum H.

AU - Hirth, Jacqueline

AU - McGrath, Christine J.

AU - Rahman, Mahbubur

PY - 2014/7/1

Y1 - 2014/7/1

N2 - The purpose of this study was to examine the relationship between human papillomavirus (HPV) vaccine uptake among adolescents aged 9-17 years and the decision-making process used by families in determining whether to vaccinate their children against HPV. A cross-sectional sample of women with at least one child aged 9-17 years (n = 1256) was recruited from 3 reproductive health clinics in Southeast Texas during 2011-2013. Self-administered survey included questions about the HPV vaccination decision-making process, HPV vaccine uptake (initiation and 3-dose series completion), and demographics. Among mothers with at least one 9 to 17-year-old daughter (n = 783), 40% independently decided whether or not to vaccinate their daughter against HPV, 22% involved their husbands/partners, and 31% their daughters. Only 7% of respondents reported other formats in the decision-making (husband/partner alone or daughter alone). Similarly, for women with at least one eligible son (n = 759), 39% decided alone, 30% with their husbands/partners, 24% with their sons, and 7% reported other formats. Among mothers with a daughter, those who made the decision independently were more likely to report that their daughters had initiated the HPV vaccine series (30%) compared with women who included their husbands/partners (10%) or daughters (20%) in the decision process or stated other types (18%) of decision making (P < 0.001). The respective figures for the completion of the entire series among daughters were 16%, 6%, 11%, and 11% (P = 0.012). Among mothers with a son, a similar scenario was observed for vaccine initiation (17%, 4%, 10%, and 0%, respectively) (P < 0.001) and completion (7%, 1%, 4%, and 0%, respectively) (P = 0.003). These associations remained significant after adjusting for confounder variables. Awareness programs to increase HPV vaccine uptake should include both parents and children, as all have an important role in deciding whether or not children will be vaccinated.

AB - The purpose of this study was to examine the relationship between human papillomavirus (HPV) vaccine uptake among adolescents aged 9-17 years and the decision-making process used by families in determining whether to vaccinate their children against HPV. A cross-sectional sample of women with at least one child aged 9-17 years (n = 1256) was recruited from 3 reproductive health clinics in Southeast Texas during 2011-2013. Self-administered survey included questions about the HPV vaccination decision-making process, HPV vaccine uptake (initiation and 3-dose series completion), and demographics. Among mothers with at least one 9 to 17-year-old daughter (n = 783), 40% independently decided whether or not to vaccinate their daughter against HPV, 22% involved their husbands/partners, and 31% their daughters. Only 7% of respondents reported other formats in the decision-making (husband/partner alone or daughter alone). Similarly, for women with at least one eligible son (n = 759), 39% decided alone, 30% with their husbands/partners, 24% with their sons, and 7% reported other formats. Among mothers with a daughter, those who made the decision independently were more likely to report that their daughters had initiated the HPV vaccine series (30%) compared with women who included their husbands/partners (10%) or daughters (20%) in the decision process or stated other types (18%) of decision making (P < 0.001). The respective figures for the completion of the entire series among daughters were 16%, 6%, 11%, and 11% (P = 0.012). Among mothers with a son, a similar scenario was observed for vaccine initiation (17%, 4%, 10%, and 0%, respectively) (P < 0.001) and completion (7%, 1%, 4%, and 0%, respectively) (P = 0.003). These associations remained significant after adjusting for confounder variables. Awareness programs to increase HPV vaccine uptake should include both parents and children, as all have an important role in deciding whether or not children will be vaccinated.

KW - Adolescents

KW - Decision-making

KW - HPV vaccine

KW - Human papillomavirus

KW - Parents

UR - http://www.scopus.com/inward/record.url?scp=84907267617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907267617&partnerID=8YFLogxK

U2 - 10.4161/hv.28779

DO - 10.4161/hv.28779

M3 - Article

C2 - 25424786

AN - SCOPUS:84907267617

VL - 10

SP - 1807

EP - 1811

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 7

ER -